Amyris Completes First Major License For RNA COVID Vaccine Advancing Technology To Human Trials

https://www.prnewswire.com/news-releases/amyris-completes-first-major-license-for-leading-rna-vaccine-advancing-technology-to-human-trials-301324193.html
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.